Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial

GEM3 Collaborative

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalThe Lancet
Volume401
Early online date1 Feb 2023
DOIs
Publication statusPublished - 25 Feb 2023

Cite this